Pharmaceuticals & Biotechnology Editor | 09/16/2011
Tenna Juul Schroder, Head of Department, Molecular Pharmacology, Lundbeck, shares her insights on compound management in an ever-changing organisation and discusses new compound management strategies involving outsourcing to CROs, to be able to support projects with a more flexible solution for hit finding.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More